Sleep

Somryst, the Prescription CBT-I App, Explained

Save

Most sleep apps you can simply download. Somryst is different: it is a prescription, cleared as a medical treatment and gated behind a clinician. This explains what it is, what it treats, how a prescription-only app actually reaches you, how it compares with sleeping pills, and why getting the same treatment may be simpler than you expect.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

What Somryst is

Somryst is a prescription digital therapeutic — a software-based treatment, authorized as a medical product, that runs as an app on a phone. What it delivers is CBT-I: a structured, multi-week program of sleep restriction, stimulus control, and cognitive techniques for the thoughts that keep people awake. It is meant for adults with chronic insomnia, which means trouble falling or staying asleep at least three nights a week for more than three months and not fully explained by another condition 1. National guidance already names CBT-I, not a pill, as the recommended treatment for that problem, alongside healthy sleep habits 1.

Why an app needs a prescription

Calling software a prescription can sound odd, so it is worth unpacking. A prescription digital therapeutic is regulated as a medical treatment: it goes through a formal authorization process, is intended to treat a specific condition, and is made available through a clinician rather than an open download. The prescription requirement is not a paywall trick; it is what puts a clinician in the loop to confirm the diagnosis, rule out problems that need a different work-up, and check that a self-paced behavioral program is a reasonable fit. That clinician involvement is part of what separates a regulated therapeutic from the thousands of unregulated sleep apps that make similar promises with no oversight at all.

How it treats insomnia — the components

The engine inside Somryst is the same behavioral method proven in clinics, delivered by algorithm rather than across a desk. Sleep restriction works by briefly capping the hours you spend in bed so that time asleep and time in bed line up again, which strengthens the drive to sleep; across randomized trials this one technique delivers moderate-to-large reductions in insomnia severity 2. Stimulus control uses a short set of bedroom rules to re-teach the brain that bed means sleep, and a pooled network analysis rates it effective on its own 3. Delivering the therapy through software is not a downgrade in principle: a large trial of a fully digital course lifted not just sleep but daytime functioning and wellbeing 4. Somryst gathers those methods into a guided, self-paced program.

How a course works in practice

In practice, the program runs over several weeks rather than a single sitting. You log your sleep each night, and the app uses that record to set and then adjust a personalized sleep schedule — tightening the window when sleep is fragmented and widening it as sleep consolidates. Lessons introduce stimulus-control rules and ways to defuse the anxious, clock-watching thoughts that keep people awake. Because the method depends on real nights of data, it cannot be rushed into a weekend, and the temporary sleep loss early on is expected rather than a sign it is failing. Most people work through it in a matter of weeks, not open-ended use.

How do you actually get it?

Because Somryst is a prescription, you cannot download it and start; a licensed clinician has to prescribe it, after which you receive access to the program. In practice that clinician might be a primary-care doctor, a psychiatrist, or a telehealth prescriber. This gate exists because a prescription digital therapeutic is regulated as a treatment, not a wellness product. One irony is worth naming: prescription CBT-I apps were created in part because human specialists in this therapy are so thin on the ground — a survey of where they practice found them bunched into a few states, with wide areas served by none 5. The market for these products has also shifted over time, so a prescriber is the right person to confirm what is currently available and prescribable rather than relying on an older web page. There is also no way to buy it outright the way you would a supplement, and that is deliberate: the gate is the diagnosis and the clinician, not a store checkout. If a prescriber does not offer it, the reasonable next question is whether they can point you to another route to the same CBT-I — in person, by video, or through a non-prescription program that teaches the identical methods.

Somryst versus sleeping pills

The pitch for a treatment like Somryst is that it addresses insomnia without a nightly drug — and the common prescription sleep medications carry real trade-offs. The FDA placed a boxed warning, its most serious, on the z-drugs eszopiclone, zaleplon, and zolpidem after rare but serious injuries from complex sleep behaviors such as sleep-walking and sleep-driving, which can occur even after a single dose 6. That is not a reason to fear every sleeping pill, but it is why a durable, drug-free treatment is appealing as a first move, and why clinical guidelines place CBT-I ahead of medication for chronic insomnia. A treatment you complete, rather than take every night, is the whole selling point.

What Somryst is not, and who it may not fit

A prescription app is still a self-paced behavioral program, and it asks real effort — chiefly the temporary discomfort of sleep restriction — so people who do not engage get less from it. It is designed for chronic insomnia, not for a night of loud snoring and morning exhaustion — a pattern that suggests sleep apnea and warrants its own assessment before any insomnia program. And like any app, it cannot examine you or find a medical or psychiatric problem sitting underneath the insomnia. Prescription status is a marker of regulation and clinician involvement; it is not a promise that the program will work for every person or replace a needed medical work-up.

The bigger picture: one route to CBT-I among several

It helps to remember that Somryst is a delivery vehicle for CBT-I, not a unique therapy. The same evidence-based methods reach people through a clinician by video, through some employer programs, and through other digital cbt-i products; the trade-offs of free vs paid cbt-i are worth weighing before you pay. If you are considering medication instead, it is worth seeing prescription sleep medications, side by side on their benefits and harms, and understanding the particular sleeping pill risks in older adults, before defaulting to a nightly drug. The through-line is simple: getting real CBT-I — by whatever route reaches you — is the first-line move, and a prescription app is just one door to it.

Common questions

It is a prescription-only app that treats chronic insomnia by delivering cognitive behavioral therapy for insomnia — the same sleep restriction, stimulus control, and cognitive techniques a clinician would use — as a structured, multi-week digital program. It is authorized as a medical treatment rather than sold like an ordinary wellness app, which is why a clinician has to prescribe it.

Through a licensed clinician, who prescribes it after confirming you have chronic insomnia and that a self-guided behavioral program is appropriate. Because the market for prescription digital therapeutics has changed over time, the practical first step is asking a prescriber what is currently available, rather than assuming any single product is still on offer.

It offers CBT-I, the guideline-recommended first-line treatment, which tends to keep its gains after the program ends — something pills do not do. The common z-drugs also carry a boxed warning for rare but serious sleep behaviors. That said, medication is right for some people, and the choice belongs with a clinician who knows your history.

Yes — that is the point of the prescription. A clinician confirms the diagnosis, rules out other causes such as sleep apnea, and checks that a behavioral program fits your situation. The app delivers the treatment; the clinician makes sure it is the right treatment and that nothing more serious is being missed.

Often, yes. CBT-I is available from a clinician in person or by video, through structured self-help workbooks, and through non-prescription digital programs that deliver the same methods. The prescription version adds regulatory authorization and a clinician in the loop, but the underlying treatment — sleep restriction, stimulus control, cognitive work — is the same either way.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

If things feel heavy, a person is available anytime — call or text 988.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When insomnia needs a clinician, not just an app

  • Heavy snoring, gasping, or witnessed breathing pauses, or daytime sleepiness that hints at sleep apnea
  • Insomnia layered on top of depression, a low mood that will not lift, or thoughts of self-harm
  • New and severe sleeplessness accompanied by tremor, sweating, a racing pulse, or unexplained weight loss
  • Sleep-walking, sleep-driving, or acting out dreams

If you are having thoughts of harming yourself, contact the Suicide and Crisis Lifeline right away by calling or texting 988.

This article describes the Somryst prescription digital therapeutic for general education. It is not medical advice; only a clinician can diagnose insomnia and decide whether a specific treatment is appropriate, and product availability can change.

References

  1. 1.National Heart, Lung, and Blood Institute (2022). Insomnia — What Is Insomnia?. NHLBI, National Institutes of Health. linkChronic insomnia is trouble falling or staying asleep at least three nights a week for more than three months, not fully explained by another condition; CBT-I and healthy sleep habits are recommended.
  2. 2.Maurer LF, Schneider J, Miller CB, Espie CA, Kyle SD (2021). The clinical effects of sleep restriction therapy for insomnia: A meta-analysis of randomised controlled trials. Sleep Medicine Reviews. linkStandalone sleep restriction therapy produces medium-to-large improvements in insomnia severity and sleep efficiency.
  3. 3.Verreault MD, Granger E, Neveu X, Delage JP, Bastien CH, Vallieres A (2024). The effectiveness of stimulus control in cognitive behavioural therapy for insomnia in adults: A systematic review and network meta-analysis. Journal of Sleep Research. doi:10.1111/jsr.14008Stimulus control is an efficacious component of CBT-I in its own right.
  4. 4.Espie CA, Emsley R, Kyle SD, et al. (2019). Effect of Digital Cognitive Behavioral Therapy for Insomnia on Health, Psychological Well-being, and Sleep-Related Quality of Life: A Randomized Clinical Trial. JAMA Psychiatry. doi:10.1001/jamapsychiatry.2018.2745A large RCT of digital CBT-I improved sleep, daytime function, psychological well-being, and sleep-related quality of life.
  5. 5.Thomas A, Grandner M, Nowakowski S, Nesom G, Corbitt C, Perlis ML (2016). Where are the Behavioral Sleep Medicine Providers and Where are They Needed? A Geographic Assessment. Behavioral Sleep Medicine. doi:10.1080/15402002.2016.1173551Behavioral sleep medicine / CBT-I providers are scarce and concentrated in a few states, leaving many areas with no local provider.
  6. 6.US Food and Drug Administration (2019). Certain Prescription Insomnia Medicines: New Boxed Warning — Due to Risk of Serious Injuries Caused by Sleepwalking, Sleep Driving and Engaging in Other Activities While Not Fully Awake. FDA Drug Safety Communication. linkThe FDA added a boxed warning for the z-drugs eszopiclone, zaleplon, and zolpidem after rare but serious injuries from complex sleep behaviors that can occur even after a single dose.

6 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy